12 High Growth Healthcare Stocks to Buy
The healthcare sector proved its mettle in 2022.
Arrowhead Pharmaceuticals Inc. (ARWR)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. I will now hand the conference over to Vincent Anzalone, Vice President of Investor Relations for Arrowhead.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode.
Baron Funds Sold Arrowhead Pharmaceuticals (ARWR) to Reallocate to Higher Conviction Ideas
Baron Funds, an asset management company, released its “Baron Global Advantage Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.
Baron Funds: "We Retain Conviction in Arrowhead (ARWR)"
Baron Funds, an asset management firm, published its “Baron Opportunity Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
Top 5 Stock Picks of Frank Fu's CaaS Capital
In this article, we discuss the top 5 stock picks of Frank Fu's CaaS Capital.
Should I Avoid Arrowhead Pharmaceuticals Inc. (ARWR)?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Is it a Good Thing to Keep Your Arrowhead Pharmaceuticals (ARWR) Shares?
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Is Arrowhead Pharmaceuticals (ARWR) Still a Great Investment Pick?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Piling Into Arrowhead Pharmaceuticals Inc. (ARWR)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
